scholarly journals Primary Care Provider Knowledge and Practice in Risk Assessment for Early Age Onset Colorectal Cancer: Opportunities for Improvement

2021 ◽  
Vol 26 (4) ◽  
pp. 298-303
Author(s):  
Anjali Parekh ◽  
Camille J. Hochheimer ◽  
Jeannine M. Espinoza ◽  
Jordan J. Karlitz ◽  
Carmen L. Lewis ◽  
...  
2014 ◽  
Vol 146 (5) ◽  
pp. S-916-S-917
Author(s):  
Eimile Dalton-Fitzgerald ◽  
Jasmin A. Tiro ◽  
Pragathi Kandunoori ◽  
Adam Yopp ◽  
Amit G. Singal

Cancer ◽  
2004 ◽  
Vol 100 (9) ◽  
pp. 1843-1852 ◽  
Author(s):  
Gareth S. Dulai ◽  
Melissa M. Farmer ◽  
Patricia A. Ganz ◽  
Coen A. Bernaards ◽  
Karen Qi ◽  
...  

2019 ◽  
Vol 3 (5) ◽  
pp. 197-203
Author(s):  
Jill Tinmouth ◽  
Jigisha Patel ◽  
Peter C Austin ◽  
Nancy N Baxter ◽  
Melissa C Brouwers ◽  
...  

Abstract Background Colorectal cancer (CRC) screening with guaiac fecal occult blood test (gFOBT) reduces CRC-related death. Average risk individuals should be recalled for screening with gFOBT every 2 years in order to maximize effectiveness. However, adherence with repeated testing is often suboptimal. Our aim was to evaluate whether adding a gFOBT kit to a mailed recall letter improves participation compared with a mailed recall letter alone, among previous responders to a mailed invitation. Methods We conducted a cluster randomized controlled trial, with the primary care provider as the unit of randomization. Eligible patients had completed a gFOBT and tested negative in an earlier pilot study and were now due for recall. The intervention group received a mailed CRC screening recall letter from their primary care provider plus a gFOBT kit (n = 431) while the control group received a mailed CRC screening mailed recall letter alone (n = 452). The primary outcome was the uptake of gFOBT or colonoscopy within 6 months. Results gFOBT uptake was higher in the intervention group (61.3%, n = 264) compared with the control group (50.4%, n = 228) with an absolute difference between the two groups of 10.8% (95% confidence interval [CI]: 1.4 to 20.2%, P = <0.01). Patients in the intervention group were more likely to complete the gFOBT compared with the control group (odds ratio [OR] = 1.4; 95% CI: 1.1 to 1.9). Conclusion Our findings show that adding gFOBT kits to the mailed recall letter increased participation among persons recalled for screening. Nine gFOBT kits would have to be sent by mail in order to screen one additional person.


Sign in / Sign up

Export Citation Format

Share Document